Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes-Reference-Cited by-同舟云学术

Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes

Published:2019-01-29 Issue:5 Volume:62 Page:2348-2361
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Li Shiliang¹^ORCID,Qin Chun¹,Cui Shichao²³,Xu Hongling¹,Wu Fangshu¹,Wang Jiawei¹,Su Mingbo²,Fang Xiaoyu¹,Li Dan²,Jiao Qian¹,Zhang Ming¹,Xia Chunmei²,Zhu Lili¹,Wang Rui¹,Li Jia²,Jiang Hualiang²,Zhao Zhenjiang¹,Li Jingya²³,Li Honglin¹^ORCID

Affiliation:

1. Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China

2. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

3. University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, P. R. China

Funder

Ministry of Education of the People's Republic of China

Ministry of Science and Technology of the People's Republic of China

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Chinese Academy of Sciences

Central Committee of the Communist Party of China

Publisher

American Chemical Society (ACS)

Subject